Table 2. Characteristics of patients who were treated by minimally invasive means 2012–2016.
| Variables | Overall (N=173) |
|---|---|
| Age, median (range) (years) | 68.0 (35.0–83.0) |
| Sex (%) | |
| Male | 139 (80.3) |
| Female | 34 (19.7) |
| ASA* (%) | |
| 0 | 2 (1.2) |
| 1 | 61 (36.3) |
| 2 | 93 (55.4) |
| 3 | 11 (6.5) |
| 4 | 1 (0.6) |
| Histological type (%) | |
| Adenocarcinoma | 133 (76.9) |
| Squamous cell carcinoma | 34 (19.7) |
| Other | 6 (3.5) |
| Neoadjuvant treatment (%) | |
| None | 48 (27.7) |
| Chemotherapy | 17 (9.8) |
| Chemoradiotherapy | 108 (62.4) |
| Tumor location (%) | |
| Upper third | 4 (2.3) |
| Middle third | 28 (16.2) |
| Lower third | 6 (3.5) |
| Junction | 134 (77.5) |
| Missing data | 1 (0.6) |
| Stage (%) | |
| 0 | 30 (17.3) |
| I | 33 (19.1) |
| II | 44 (25.4) |
| III | 57 (32.9) |
| Other | 3 (1.7) |
| Not arrived | 6 (3.5) |
*, Missing data: 5.